Get started
Author

Emelie Curovic Rotbain

Observed names: Curovic Rotbain, Emelie, E. Curovic Rotbain, Emelie C Rotbain, Emelie C. Rotbain, Emelie Hamotal Curovic Rotbain, Emelie Hamotal Curovic-Rotbain, Emelie Rotbain, Rotbain EC, Rotbain, Emelie, Rotbain, Emelie Curovic
Observed institutions: Statens Serum Institut, University of Southern Denmark, Odense University Hospital, Copenhagen University Hospital, Rigshospitalet, Danish Cancer Society
ORCID: 0000-0002-4199-772X
Observed ORCID: 0000-0002-4199-772X
OpenAlex ID: A5031331400
Mapping comorbidity in chronic lymphocytic leukemia: impact of individual comorbidities on treatment, mortality, and causes of death
2021 · Emelie Curovic Rotbain, Carsten Utoft Niemann, et al. · Leukemia · 55
PDF
Real‐world outcomes for 205 patients with chronic lymphocytic leukemia treated with ibrutinib
2020 · Kathrine Aarup, Emelie Curovic Rotbain, et al. · European Journal Of Haematology · 55
PDF
Splenomegaly – Diagnostic validity, work-up, and underlying causes
2017 · Emelie Curovic Rotbain, Dennis Lund Hansen, et al. · PLoS ONE · 54
PDF
Development and Validation of a Nordic Multimorbidity Index Based on Hospital Diagnoses and Filled Prescriptions
2022 · Kasper Bruun Kristensen, Lars Christian Lund, et al. · Clinical Epidemiology · 44
PDF
IGHV mutational status and outcome for patients with chronic lymphocytic leukemia upon treatment: a Danish nationwide population-based study
2019 · Emelie Curovic Rotbain, Henrik Frederiksen, et al. · Haematologica · 37
PDF
The CLL comorbidity index in a population-based cohort: a tool for clinical care and research
2022 · Emelie C. Rotbain, Max J. Gordon, et al. · Blood Advances · 26
PDF
Risk of new malignancies among patients with CLL treated with chemotherapy: results of a Danish population‐based study
2021 · Caspar da Cunha‐Bang, Klaus Rostgaard, et al. · British Journal of Haematology · 22
PDF
Ruminococcus gnavus bacteraemia in a patient with multiple haematological malignancies
2019 · Caroline Gren, Malene Roed Spiegelhauer, et al. · Access Microbiology · 20
The Danish Lymphoid Cancer Research (DALY-CARE) Data Resource: The Basis for Developing Data-Driven Hematology
2025 · Christian Brieghel, Mikkel Werling, et al. · Clinical Epidemiology · 13
PDF
Healthcare Utilization and Comorbidity in Chronic Lymphocytic Leukemia
2021 · Emelie C Rotbain, Klaus Rostgaard, et al. · Clinical Epidemiology · 11
PDF
Infections and their prognostic significance before diagnosis of chronic lymphocytic leukemia, non-Hodgkin lymphoma, or multiple myeloma
2024 · Esben Packness, Olafur Birgir Davidsson, et al. · British Journal of Cancer · 10
PDF
Identifying CLL patients at high risk of atrial fibrillation on treatment using machine learning
2024 · Mehdi Parviz, Rudi Agius, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 10
Venetoclax combinations in untreated CLL: 5-year results and patient-reported outcomes analysis of the CLL13/GAIA trial
2026 · Moritz Fürstenau, Carsten U. Niemann, et al. · Blood · 9
Real‐world outcomes upon second‐line treatment in patients with chronic lymphocytic leukaemia
2023 · Noomi Vainer, Kathrine Aarup, et al. · British Journal of Haematology · 9
PDF
Polypharmacy independently predicts survival, hospitalization, and infections in patients with lymphoid cancer
2025 · Christian Brieghel, Thomas Lacoppidan, et al. · HemaSphere · 8
PDF
Cost-effectiveness of targeted treatment vs chemoimmunotherapy in treatment-naive unfit CLL without TP53 aberrations
2023 · Matilde Slot, Carsten Utoft Niemann, et al. · Blood Advances · 7
PDF
CLL-IPI applied in Binet A CLL: a nationwide cohort study
2022 · Emelie C. Rotbain, Caspar da Cunha-Bang, et al. · Blood Advances · 6
Impact of type 2 diabetes on mortality, cause of death, and treatment in chronic lymphocytic leukemia
2023 · Emelie Curovic Rotbain, Cristine Allmer, et al. · American Journal of Hematology · 5
PDF
Mapping Comorbidity in CLL: Impact on Prognostic Factors, Treatment Patterns and Causes of Death
2019 · Emelie Curovic Rotbain, Carsten Utoft Niemann, et al. · Blood · 5
Understanding and Managing Infectious Complications in Chronic Lymphocytic Leukemia
2025 · Noomi Vainer, Andreas Katsimigas, et al. · Hematology/Oncology Clinics of North America · 3
The risk of myelodysplastic syndrome and acute myeloid leukemia by metformin use and type 2 diabetes status – a Danish nation-wide cohort study
2025 · Emelie C. Rotbain, Klaus Rostgaard, et al. · Acta Oncologica · 3
PDF
Spontaneous regression in chronic lymphocytic leukaemia. Clinical features of 50 cases from the ERIC registry and review of the literature
2023 · Ilaria Del Giudice, Luca Vincenzo Cappelli, et al. · British Journal of Haematology · 3
PDF
Comparison of Frontline Therapies in Older Adults Age ≥ 80 Years With Chronic Lymphocytic Leukemia ( CLL ): A Mayo Clinic and Danish Nation‐Wide Study
2025 · Mazie Tsang, Paul J. Hampel, et al. · American Journal of Hematology · 2
PDF
Patient-Reported Quality of Life Outcomes with Venetoclax-Based First-Line Combinations in CLL: An Analysis from the Phase 3 GAIA/CLL13 Trial
2024 · Moritz Fürstenau, Emelie Curovic Rotbain, et al. · Blood · 2
PDF
Quality of Life in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia Improves after Minimal Residual Disease-Guided Treatment with Ibrutinib Plus Venetoclax
2024 · Laura Elisabeth Maria Eurelings, Emelie Curovic Rotbain, et al. · Blood · 2
Works count: 50
Citation count: 430
H-index: 10
I10-index: 12
Year
Topic
Type